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The small guanine nucleotide binding
proteins of the Ras family, including in
mammals the highly homologous H-ras,
N-ras, and K-ras isoforms, are rapidly
activated on ligation of the T-cell anti-
gen receptor (TCR), but whether each
isoform plays specific roles in T cells is
largely unknown. Here, we show, with
the use of mice specifically lacking H-
ras or N-ras, that these isoforms are
dispensable for thymocyte develop-
ment and mature T-cell activation. By
contrast, CD4 T cells from Ras-deficient
mice exhibited markedly decreased pro-
duction of the Th1 signature cytokine
IFN- early after TCR stimulation, con-
comitantly with impaired induction of the
Th1-specific transcription factor T-bet. Ac-
cordingly, Ras-deficient mice failed to
mount a protective Th1 response in vivo
against the intracellular parasite Leishma-
nia major, although they could be ren-
dered resistant to infection if a Th1-
biased milieu was provided during
parasite challenge. Collectively, our data
indicate that the TCR recruits distinct Ras
isoforms for signal transduction in devel-
oping and mature T cells, thus providing
a mechanism for differential signaling
from the same surface receptor. Further-
more, we demonstrate for the first time
that H-ras and N-ras act as critical control-
lers of Th1 responses, mostly by transmit-
ting TCR signals for Th1 priming of CD4
T cells. (Blood. 2011;117(19):5102-5111)
Introduction
T cells differentiate in the thymus from CD4CD8 precursors. In
the peripheral lymphoid organs, mature CD4 T cells undergo
further differentiation and become T helper effectors which medi-
ate, among others, Th1 and Th2 immune responses controlling
intracellular and extracellular pathogen infections, respectively,
allergy, and autoimmunity.1,2 Both differentiation processes are
initiated by signals emanating from the TCR. However, the
signaling pathways differentially triggered by the TCR during
thymic and peripheral differentiation of T cells are not fully
understood.
The small guanine nucleotide binding proteins of the Ras
family,3 encompassing in mammals the highly homologous H-ras,
N-ras, and K-ras (4A and 4B splice variants) isoforms, are rapidly
activated after TCR engagement.4-6 Each of the 3 mammalian Ras
genes encodes a membrane-associated 21-kDa protein that acts as a
molecular switch to convey extracellularly derived signals into the
cell interior. Ras proteins cycle between an inactive GDP-bound
state and an active GTP-bound state, because of the concerted
action of guanine nucleotide exchange factors (GEFs) and GTPase-
activating proteins.7 GEFs catalyze the release of GDP, allowing
binding of the more abundant GTP and inducing a conformational
change in the proteins that allow them to interact with their
downstream effectors. GTPase-activating proteins, however, stimu-
late the intrinsic GTPase activity of Ras proteins and therefore
catalyze their inactivation.
The best-characterized Ras effectors are the Raf kinases,
through which Ras activates the MAPK cascade, the PI3Ks, and
a family of Ral GEFs.7 Although Ras proteins are ubiquitously
expressed, differences in their expression in various tissues and
during development,3 along with a distinct subcellular distribu-
tion and recruitment of downstream effectors,8 suggest that each
Ras isoform may subsume a specialized and specific function.
Ras signaling downstream of the TCR has been implicated in
several aspects of T-cell biology,9,10 including thymocyte selec-
tion11 and Th differentiation.12 However, most of these studies
are based on analyses of transgenic mice expressing a dominant-
negative Ras mutant protein, which, because of its mechanism
of action (ie sequestration of activating GEFs13), cannot discrimi-
nate between contributions from different isoforms or from
other members of the Ras superfamily.14 This limitation can be
partly overcome by analyzing gene-targeted mice specifically
lacking individual Ras isoforms. Mice lacking H-ras15 or N-ras16
develop and reproduce normally, whereas deletion of K-ras
results in embryonic lethality.17 We therefore analyzed T-cell
differentiation and function in mice deficient for H-ras or N-ras.
Our analyses showed hitherto unidentified functions of H-ras
and N-ras in regulating early IFN- expression and Th1
responses and provided supporting evidence for their dispensabil-
ity during thymocyte development and mature T-cell activation.
Thus, our results suggest that Ras isoforms, although closely
related, have nevertheless evolved to control differentiation
programs triggered by the TCR at distinct stages of T-cell
maturation.
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Methods
Mice and reagents
H-ras– and N-ras–deficient mice have been previously described.15,16
C57BL/6 mice used as wild-type (WT) controls and BALB/c mice were
purchased from Harlan Interfauna Ibe´rica. AND TCR and OT-I TCR
transgenic mice (H-2b background) have been described elsewhere.18,19
Transgenic TCRs were independently introduced onto the Ras-deficient
background by breeding TCR transgenic with H-ras knockout (KO) or
N-ras KO mice. F1 littermates expressing the transgenic TCR, as deter-
mined by flow cytometry in blood T cells, were bred further to obtain
Ras-sufficient (/) and Ras KO (/) TCR transgenic animals. Ras
genotype was determined by PCR, as previously described.15 For experi-
ments of Leishmania major infection, Ras-deficient mice were bred on a
C57BL/6 background for  6 generations. All animal experiments were
done according to institutional guidelines. Antibodies were obtained from
BD Biosciences and Santa Cruz Biotechnology. Soluble leishmanial
antigen (SLA) was prepared as previously described.20 Lipopolysaccharide
(LPS) and concanavalin A were obtained from Sigma-Aldrich. Phosphoro-
thioate-modified CpG-oligodeoxynucleotide (ODN; 5-TCAACGTTGA-3
and 5-GCTAGCGTTAGCGT-3) were synthesized by Isogen. Cytokines
were purchased from R&D Systems.
TCR stimulation
Cells were cultured for 48 hours in RPMI 1640 supplemented with 10%
FCS, 2mM L-glutamine, and 50 U/mL penicillin/streptomycin, in 96-well
plates (5  105 cells per well) coated with 1 g of anti-CD3 in the presence
or absence of 0.5 g of soluble anti-CD28. AND TCR thymocytes were
stimulated by coculture for 48 hours with I-Ek– and ICAM-1–expressing
DCEK fibroblasts loaded with various amounts of moth cytochrome
c 81-103 peptide (VFAGLKKANERADLIAYLKQATK). For biochemical
analysis, cells were resuspended in PBS and incubated for 10 minutes at
4°C in the presence or absence of biotin-conjugated anti-CD3 (145-2C11)
and anti-CD4 (RM4-5) antibodies. After removal of unbound antibody, the
cells were incubated at 37°C for various periods of time with 100 g/mL
streptavidin.
Immunoblotting
After stimulation, cells were lysed in a buffer containing 1% Brij-96, 20mM
Tris-HCL pH 7.8, 150mM NaCl, and a cocktail of protease and phosphatase
inhibitors. Total cell lysates were resolved by SDS-PAGE, transferred to
Immobilon-P (Millipore) membranes, and immunoblotted with specific
antibodies. Bound antibodies were detected with an enhanced chemilumi-
nescence system (Amersham).
Flow cytometry
Cells were stained with specific fluorochrome-conjugated or biotinylated
antibodies revealed with PE–cyanine 5–streptavidin and analyzed by flow
cytometry in a FACSCalibur cytometer with Cellquest software (Becton
Dickinson).
Proliferation, cytokine, and NO production assays
Proliferation was determined by incorporation of [3H]-thymidine, as
described.21 The methods for cytokine measurement by intracellular
cytokine staining and ELISA have been described.20 Briefly, for intracellu-
lar cytokine staining, cells were cultured in the presence of Golgi transport
inhibitor for the final 4 hours of culture. Cells were then surface-stained
with anti–CD4-PerCP, followed by fixation and permeabilization with
Cytofix/Cytoperm (BD Biosciences) according to the manufacturer’s
protocol. Finally, cells were stained with anti–IFN-–FITC and anti–
IL-4–PE and analyzed by flow cytometry. For ELISA assays, 3  106 cells
were seeded in 48-well plates at 37°C for 48 hours in the presence or
absence of SLA (12 g/mL). The release of IFN- and IL-4 was measured
in the culture supernatant fluids with ELISA kits from Diaclone and
eBioscience, respectively. IL-12 was assessed with an ELISA kit from
eBioscience. IL-2 was measured by fluorescent bead assay (Bender
MedSystems), following the manufacturer’s instructions. NO was mea-
sured as nitrite with the use of the Greiss reaction.22
BM-derived dendritic cells and macrophages
Cells from BM were cultured for 7 days in the presence of GM-CSF
(20 ng/mL; PeproTech) or M-CSF (10 ng/mL; Sigma) to generate dendritic
cells (DCs) and macrophages, respectively.
Parasites and infection
The methods used for parasite growth, challenge, and quantification have
been described.20 Briefly, infection was performed by intradermal inocula-
tion in the ear of 300 metacyclic promastigotes (in 15 L of PBS) of
L major (clone V1). The evolution of the infection was monitored by
measuring the diameter of the induration of the ear lesion with a metric
caliper. The number of parasites was determined by limiting dilution assay.
Statistical analysis
To analyze statistical significance, we used an unpaired Student t test.
P values  .05 were considered to be significant.
Results
Unimpaired thymocyte development and positive selection in
mice lacking H-ras or N-ras
To evaluate the effects of the H-ras and N-ras deficiency on T-cell
development, we first examined the different thymocyte subpopula-
tions defined by expression of CD4 and CD8 in WT and Ras-
deficient mice (Figure 1A; Table 1). Percentages and numbers of
double-negative CD4CD8, double-positive CD4CD8, and
single-positive (SP) CD4 or CD8 cells present in H-ras– and
N-ras–deficient thymuses were comparable to those of WT
mice.15,16,23 Frequencies of mature CD4 and CD8 SP cells in the
spleen were also similar between Ras-deficient and control mice.
Further, the pattern of TCR expression, measured by CD3 staining,
in thymocytes and spleen CD4 T cells of Ras-deficient mice was
indistinguishable from that of WT mice (Figure 1A bottom panels).
To study thymocyte development in more detail, we introduced
the MHC class II–restricted cytochrome c-specific AND TCR
transgene18 onto the H-ras– and N-ras–deficient background and
analyzed positive selection. In Ras-deficient mice, positively
selected CD4 SP T cells expressing the AND TCR were similar to
their counterparts in Ras-sufficient littermate controls with regard
to cell frequencies and numbers (Figure 1B-C) and surface
expression of the transgenic TCR (Figure 1B bottom panels).
Because a major criterion for positive selection is responsiveness to
cognate antigen, we challenged Ras-sufficient and -deficient thymo-
cytes with antigen in vitro and assessed CD69 up-regulation in
positively selected CD4 SP cells. The pattern of CD69 up-
regulation in response to antigenic peptide of H-ras– and N-ras–
deficient CD4 SP cells was comparable to that of their sufficient
counterparts (Figure 1D). Moreover, positive selection of OT-I
TCR19 transgenic CD8 SP thymocytes proceeded normally in
Ras-deficient mice (Figure 1E). Collectively, these data suggest
that TCR-derived signals responsible for thymocyte positive selec-
tion remain mostly undisturbed in the absence of H-ras or N-ras.
Further supporting this, activation of ERK kinases, which is critical
for positive selection,24 was not defective but moderately aug-
mented in thymocytes from mice lacking H-ras, in particular, or
N-ras (Figure 1F). Taken together, these data indicate that loss of
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either H-ras or N-ras gene function does not compromise positive
selection and differentiation in the thymus.
H-ras and N-ras are not required for TCR-mediated mature
T-cell activation
Next, we examined the roles of H-ras and N-ras in TCR-mediated
activation of peripheral T cells. For this, we stimulated splenocytes
from WT and Ras-deficient mice with anti-CD3 and anti-CD28
antibodies. Up-regulation of the early activation markers CD69 and
CD25 was similar in Ras-deficient and WT T cells (Figure 2A).
Further, stimulation of Ras-deficient splenocytes with concanava-
lin A, a T-cell mitogen, or anti-CD3 plus anti-CD28 provoked
similar or augmented release of IL-2, respectively, compared with
WT cells (Figure 2B). In correlation, H-ras– and N-ras–deficient
T cells showed enhanced proliferation in response to anti-CD3 plus
anti-CD28 stimulation compared with WT counterparts (Figure
2C). Thus, H-ras and N-ras seem to be dispensable for TCR-
mediated T-cell activation.
H-ras and N-ras deficiency impair TCR-induced IFN-
expression in CD4 T cells
The early induction of cytokine gene expression and subsequent Th
differentiation require proximal signaling events initiated by TCR
engagement,25,26 the nature of which remains poorly defined. To
Figure 1. Unaffected thymocyte development and
positive selection in mice lacking H-ras or N-ras.
(A) Cells from WT, H-ras–, and N-ras–deficient mice were
stained for expression of CD4, CD8, and CD3 and were
analyzed by flow cytometry. Numbers within dot plots
indicate percentage of cells in each quadrant. Bottom
panels show CD3 expression in thymocytes (left) and
splenic CD4 T cells (right) from WT (shaded curve),
H-ras KO (solid line), and N-ras KO (dotted line) mice.
(B) CD4 and CD8 expression in AND TCR transgenic
thymocytes (gated as TCRhi) from Ras-sufficient (/)
and deficient (/) littermate mice. Numbers indicate
percentage of cells in the gated region. Clonotypic TCR
expression in gated CD4 SP thymocytes from Ras-
sufficient (solid line) and deficient (dotted line) mice is
shown in the bottom panels. (C) CD4 SP thymocyte
numbers in Ras-sufficient and -deficient and TCR trans-
genic mice. Results from individual mice (open circles)
and the average for each population (thick bars) are
shown. (D) Thymocytes were stimulated with the indi-
cated concentration of moth cytochrome c (MCC) 81-103
peptide for 48 hours and stained for expression of CD4,
CD8, and CD69. Mean CD69 expression  SD (n 	 2) in
gated CD4 SP cells is shown. (E) CD4, CD8, and
clonotypic TCR expression in thymocytes from Ras-
sufficient and -deficient OT-I TCR transgenic mice. CD8
SP frequencies were (n 	 4): H-ras (/: 13  3.4;/:
13  2.0; P 	 .98); N-ras (/: 8.7  5.9; /:
8.9  6.0; P 	 .96). (F) ERK activation in anti–CD3-
stimulated thymocytes. Fold induction of ERK relative to
unstimulated (time 0) cells is indicated. Total AKT is
shown as loading control.
Table 1. Thymocyte subsets in WT and Ras-deficient mice
WT H-ras KO N-ras KO
Total number,  106 83  16 86  13 75  9
CD4CD8, % 84.9  2.4 83.5  2.4 (.394) 82.4  1.9 (.112)
CD4 SP, % 9.4  1.1 10.8  2.1 (0.217) 10.6  0.5 (.06)
CD8 SP, % 2.5  0.6 2.7  0.9 (.709) 2.8  0.6 (.520)
Values are mean  SD (n 	 5). P values versus WT using unpaired t test are
shown in parentheses.
SP indicates single positive.
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test whether H-ras and N-ras are implicated in early cytokine
production by CD4 T cells after TCR ligation, we stimulated
splenocytes with immobilized anti-CD3 in the presence or absence
of anti-CD28 and measured the expression of Th hallmark cyto-
kines IFN- (Th1) and IL-4 (Th2) by intracellular cytokine
staining. Anti–CD3-stimulated CD4T cells from WT mice showed
enhanced IFN- expression but only marginal induction of IL-4,
compared with nonstimulated cells. In addition, the IFN- response
was strongly enhanced further by anti-CD28 antibody (Figure 3A
top panels). In contrast, IFN- expression was consistently attenu-
ated in stimulated CD4 T cells from H-ras– and N-ras–deficient
mice, with poor additional enhancement when anti-CD28 costimu-
lation was provided (Figure 3A middle and bottom panels).
However, this impairment in IFN- expression was not accompa-
nied by a corresponding increase in the proportions of IL-4–
producing cells. The addition during Th priming of IL-12 or
CpG-containing oligodeoxynucleotides (CpG-ODNs), both potent
inducers of IFN- and Th1 differentiation,25,27 failed to restore
IFN- production to WT levels (Figure 3B). A similar defect was
observed in Th1-polarized cultures of Ras-deficient T cells at later
time points (data not shown). In addition, deliberate Th2 polariza-
tion, by the addition of IL-4 and anti–IFN- antibody, did not result
in increased frequencies of IL-4–expressing cells in Ras-deficient
compared with WT cells (Figure 3B).
The poor capacity of H-ras– and N-ras–deficient CD4 T cells
to differentiate into IFN-–producing effectors correlated with
impaired induction of T-bet (Figure 4A), a transcription factor that
plays a major role in Th1 lineage commitment in part by activating
the expression of IFN-.28 In contrast, induction of the Th2
transcription factor GATA-31 was not affected by the Ras defi-
ciency (Figure 4A). Notably, IL-12R
225 and CXCR-3,29 also gene
targets of T-bet, were normally induced in activated CD4 T cells
from Ras-deficient mice (Figure 4B-C), suggesting that expression
of T-bet–dependent genes is differentially triggered by distinct
levels of the transcription factor. Of interest, CpG-ODNs were
capable of fully rescuing the defect in T-bet induction (Figure 4A),
whereas IFN- expression (Figure 3B) was only partially improved
by CpG-ODNs in activated Ras-deficient CD4 T cells. The latter
supports the notion that, in addition to T-bet, other H-ras– and
N-ras–dependent pathways are required for optimal TCR-mediated
induction of IFN-. To any extent, these data indicate that H-ras
and N-ras play an important role in TCR-initiated signaling leading
to early induction of T-bet and IFN- in CD4 T cells.
H-ras and N-ras deficiency enhance susceptibility to L major
infection because of defective development of a protective Th1
response
Because T-bet and IFN- play a major role in Th1 development,25
we next sought to determine the effect of the H-ras and N-ras
deficiency on the generation of Th1 responses in vivo against the
intracellular parasite L major.30 Inbred genetically resistant mouse
strains such as C57BL/6 control infection by developing a curative
Th1 response. Ras-deficient mice in the C57BL/6 background, in
striking contrast to WT mice, developed progressively larger and
nonhealing lesions (Figure 5A-B) after inoculation of a low dose of
parasites into the ear dermis, which correlated with significantly
enhanced parasite burden in the infection site and draining lymph
node (LN) at week 12 after infection (Figure 5C). At an earlier
times after infection (week 3), parasite loads were still comparable
in WT and Ras-deficient mice.
One week after parasite challenge, frequencies of primed
IFN-–producing CD4 T cells were significantly reduced in
Ras-deficient compared with WT mice, but without concomitant
increase of IL-4–expressing cells (Table 2). In contrast, 12 weeks
after challenge, the cytokine response to the parasite was biased
toward a Th2-like profile dominated by IL-4 in both H-ras– and
N-ras–deficient compared with WT mice (Figure 5D). Moreover,
Th2-dependent IgG1 antibodies to the parasite were detected in
Ras-deficient but not in WT mice (data not shown). These data
clearly show that, despite their normally resistant genetic back-
ground,30 H-ras– and N-ras–deficient mice are impaired in their
ability to resolve a L major infection, probably because of defective
Th1 differentiation in these mice leading to gradual establishment
of a disease-promoting Th2 response.
Because IL-12 is required to establish Th1-mediated responses
against L major,31 and DCs are a major source of IL-12 in vivo, we
next examined whether Ras-deficient DCs might be impaired in
IL-12 production. As shown in Figure 6A, DCs lacking H-ras
exhibited slightly reduced IL-12 production compared with WT
DCs on stimulation with increasing amounts of LPS or CpG-
ODNs. By contrast, N-ras–deficient DCs produced normal or
significantly enhanced amounts of IL-12 in response to LPS or
CpG-ODNs, respectively; the latter suggesting that N-ras could act
as a negative regulator of TLR9-mediated signaling in DCs. Thus,
enhanced susceptibility of Ras-deficient mice to L major infection
is not seemingly associated with defects in IL-12 production by
DCs or in the expression of the IL-12R on activated CD4 T cells
(Figure 4B), which is also required for resistance to L major.32
Figure 2. Unimpaired TCR-mediated early T-cell activation in mice lacking H-ras
or N-ras. (A) Splenocytes from WT, H-ras–, and N-ras–deficient mice were stimu-
lated without or with anti-CD3 plus anti-CD28 mAb for 48 hours and stained for CD25
and CD69 expression. Numbers indicate percentage of cells in the gated region.
(B) IL-2 production by splenic T cells stimulated with anti-CD3 (solid line), concanava-
lin A (dotted line), or without stimulation (shaded curve), as measured after 48 hours
by fluorescent bead assay. Numbers over each curve indicate IL-2 concentration
(ng/mL). (C) Proliferation responses of unstimulated and anti–CD3/CD28-stimulated
LN T cells. Mean [3H]-thymidine incorporation  SD of triplicate cultures is shown
(*P  .05 vs WT). Results in each panel are representative of  2 independent
experiments.
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Further, LPS- or CpG-ODN–induced up-regulation of MHC class
II and costimulatory molecules in DCs was not affected by the Ras
deficiency (data not shown). However, macrophages from H-ras–
or N-ras–deficient mice were as competent as those from WT mice
to produce NO, a key effector mechanism for control and clearance
of L major30 after stimulation with IFN- or IFN- plus LPS
(Figure 6B), indicative of no primary defect in their function.
In view of the above-mentioned data, we focused on the T-cell
cytokine response during early L major infection. We infected WT
and Ras-deficient mice in the ear with 1000 metacyclic promastig-
otes of L major, and cells from the local draining LN were collected
3 weeks later, cultured with SLA-pulsed DCs from WT mice, and
assessed for cytokine production. WT DCs were used as an APC to
optimize the conditions necessary to show IFN- production by
Ras-deficient T cells, thus avoiding potential adverse effects of the
Ras deficiency on DC function. As shown in Figure 6C, LN T cells
from Ras-deficient mice exhibited impaired parasite-specific IFN-
but normal IL-4 responses compared with WT counterparts, as
measured by intracellular cytokine staining after 24 hours. Analysis
of supernatant fluids from 48-hour cultures by ELISA also showed
Figure 3. H-ras and N-ras deficiency impair TCR-induced IFN-
expression in CD4 T cells. (A) Splenic T cells from mice of the indicated
genotype were stimulated without or with anti-CD3 or anti-CD3 plus
anti-CD28 mAb during 48 hours for analysis of intracellular IFN- and IL-4
expression in gated CD4 T cells. Numbers within dot plots indicate
percentage of cells in the gated regions. (B) Splenic T cells from mice of
the indicated genotype were stimulated for 48 hours with anti-CD3 plus
anti-CD28 in the absence or presence of either IL-12 (1 ng/mL), CpG-ODN
(25 g/mL), or IL-4 (100 ng/mL) plus anti–IFN- antibody (3 g/mL) and
analyzed for intracellular IFN- and IL-4 expression in gated CD4 T cells
by flow cytometry. Numbers within dot plots indicate percentage of cells in
the gated regions.
Figure 4. T-bet and GATA-3 induction in activated
CD4 T cells from Ras-deficient mice. (A) T-bet and
GATA-3 expression in splenic CD4 T cells left unstimu-
lated (shaded curve) or stimulated with anti-CD3/CD28
antibodies for 48 hours (solid line). T-bet expression in
cells stimulated in the presence of CpG-ODN is also
shown (dotted line). Top and bottom values within histo-
grams indicate the percentage and MFI, respectively, of
cells in the marked region. (B) Unstimulated or anti–CD3-
stimulated (48 hours) splenocytes were stained for expres-
sion of CD4 and IL-12R
2. (C) CXCR3 induction in
splenic CD4 T cells stimulated with anti-CD3 antibody
for 72 hours. Numbers indicate percentage of cells in the
gated region. Results in each panel are representative of
 2 independent experiments.
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a markedly reduced SLA-specific IFN- response of both H-ras–
and N-ras–deficient T cells. Of interest, an augmented antiparasite
IL-17 (Th17) cytokine response was observed in N-ras– but not
H-ras–deficient mice (Figure 6D). This suggests that impaired Th1
differentiation in Ras mutant mice is not a common consequence of
alternative development toward the Th17 lineage. In fact, T cells
from mice lacking N-ras, but not H-ras, displayed markedly
increased production of IL-17 early after TCR engagement in vitro,
even in the absence of Th17-polarizing cytokines (L.S.-A., E.S.,
E.F.-M., unpublished observations, November 2007). Taken to-
gether with results shown in Figure 3, these data are consistent with
an intrinsic defect of H-ras– and N-ras–deficient T cells to differen-
tiate into Th1 effectors, which in turn could compromise the
development of protective immunity against L major.
CpG-ODN administration protects H-ras– and N-ras–deficient
mice from L major infection
CpG-ODNs trigger an immunomodulatory cascade that results in a
Th1-biased immune milieu.27 CpG-ODN treatment has been used
successfully to promote protective and curative Th1 responses to
L major infection in otherwise susceptible BALB/c mice.33 In
resistant C57BL/6 mice, CpG-ODNs delivered at the same site and
time of infection enhanced Th1 immunity and thereby moderated
the pathology associated with parasite infection.34 We therefore
tested whether CpG-ODNs could protect Ras-deficient mice from
L major infection. For this, mice were infected in both ears with
1000 L major metacyclic promastigotes alone or in combination
with CpG-ODNs. As previously reported,34 C57BL/6 WT mice
treated with CpG-ODNs developed an attenuated dermal pathology
compared with untreated mice (Figure 7A). Strikingly, CpG-ODN
treatment also protected H-ras– and N-ras–deficient mice from the
development of dermal lesions. This protective effect correlated
with an early and long-lasting containment of parasite growth in the
infection site (Figure 7B) and draining LN (data not shown) in both
WT and Ras-deficient mice.
We next analyzed the parasite-specific cytokine response at
week 3 after parasite challenge, when parasite burdens were
comparable in WT and Ras mutant mice either untreated (Figure
5C) or treated with CpG-ODNs (Figure 7B). As shown in Figure
7C, draining LN cells from untreated H-ras– and N-ras–deficient
mice produced IFN- but at levels markedly lower than WT cells,
further supporting a negative effect of the H-ras and N-ras
deficiency on IFN- expression in activated T cells. Of interest,
Ras-deficient T cells showed significantly higher production of
IL-4 than their WT counterparts, resembling the cytokine profile of
antigen-stimulated T cells from susceptible BALB/c mice.35 As
previously observed in vitro (Figure 3B), CpG-ODNs partly
improved IFN- production in Ras-deficient mice and particularly
in animals lacking N-ras, probably because of enhanced IL-12
release by stimulated N-ras–deficient DCs (Figure 6A), but without
reaching the levels observed in either untreated or CpG-ODN–
treated WT mice. Notably, CpG-ODN treatment completely abro-
gated the enhanced IL-4 response observed in untreated Ras-
deficient mice (Figure 7C). Thus, as previously reported for
susceptible BALB/c mice,33 the Th1-promoting activity of CpG-
ODNs in vivo seems to protect Ras-deficient mice from L major
infection by interfering with the early establishment of a Th2-type
response that facilitates parasite growth.
Discussion
Why mammals have 3 distinct Ras genes and 4 different but highly
related Ras proteins is puzzling. A possible explanation might be
that each isoform subsumes specific functions not shared by the
other family members. In this respect, our work provides the first
direct evidence that H-ras and N-ras are critically involved in the
control of T-cell differentiation in the periphery but not in the
thymus. Because K-ras 4A is not detectable in the mouse thymus,36
our findings point to K-ras 4B as the key isoform implicated in
thymocyte development.11 In line with this, activating mutations of
K-ras correlate with the appearance of thymic tumors.37 Further,
mice doubly deficient for H-ras and N-ras show grossly normal
intrathymic development.15
In a previous study with mice deficient for N-ras,23 a minor but
consistent decrease in CD8 SP thymocytes was interpreted as
Figure 5. H-ras and N-ras deficiency enhance susceptibility to L major
infection. (A) Course of L major infection in WT, H-ras–, and N-ras–deficient mice.
Mean lesion size  SD of 4-10 mice per group are shown (*P  .001 and **P  .0005
vs WT). (B) Ear lesions with focal necrosis in infected Ras-deficient but not WT mice
at week 12 after infection. (C) Parasite burden in the ear and draining LN (DLN) from
infected mice at weeks 3 and 12 after infection. Results represent mean  SD for 4
mice per group (**P  .0005 vs WT). (D) IFN- and IL-4 production, as determined by
ELISA, by draining LN cells isolated from L major–infected mice at week 12 after
infection and stimulated with SLA (12 g/mL) for 48 hours. Values represent the
mean  SD of duplicate cultures and 4 mice in each group (*P  .001 and
**P  .0005 vs WT). The data shown are representative of 2 independent experi-
ments.
Table 2. CD4 T-cell cytokine response in WT and Ras-deficient
mice early after L major challenge
WT H-ras KO N-ras KO
IFN- 17.4  1.9 5.5  0.7 (.015*) 5.8  0.5 (.041*)
IL-4 1.2  0.9 1.2  0.5 (.709) 0.8  0.3 (.520)
Values represent the percentage (mean  SD; 2 mice per group) of CD4 T cells
positive for the indicated cytokine, as determined by cytometric intracellular staining,
in anti–CD3/CD28-stimulated (48 hours) draining lymph node cells 1 week after
parasite challenge. P values versus WT using unpaired t test are shown in
parentheses.
*Significant difference.
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impaired positive selection because of N-ras deficiency. However,
TCR transgenic models were not analyzed in that study. With the
use of MHC class I– and class II–restricted transgenic TCRs
expressed in the Ras-deficient backgrounds, we show here that
N-ras or H-ras deficiency has no major effect on positive selection
of either CD4 or CD8 T cells. Furthermore, peripheral TCR
transgenic N-ras–deficient CD8 T cells were capable of mounting
effective antigen-specific primary responses (S.I., E.S., E.F.-M.,
unpublished data). Yet a role for H-ras or N-ras or both in
fine-tuning thymocyte selection, particularly that mediated by
low-affinity ligands,38 cannot be completely discarded.
H-ras and N-ras seem to also be dispensable for some T-cell
activation events triggered by the TCR, including induction of the
activation markers CD25 and CD69, IL-2 production, and prolifera-
tion. In contrast, deficiency of either H-ras or N-ras caused a defect
in TCR-induced early IFN- and T-bet expression, resulting in
affected Th1 priming of CD4 T cells. Ultimately, Ras-deficient
mice proved highly susceptible to L major infection, even though
the capacity of DCs and macrophages to produce IL-12 and NO,
respectively, which are also critical for a protective Th1 response to
the parasite,30,31 were not overtly affected by the Ras deficiency.
Early during Th1 differentiation,25 TCR-mediated stimulation
of naive CD4 T cells results in low-level expression of IFN- and
IL-4, and of both Th1-specific T-bet and Th2-specific GATA-3
transcription factors. Later, subsequent development along the Th1
lineage is thought to require signals via IL-12R and IFN-R, which
further up-regulates T-bet expression and drives high-level produc-
tion of IFN- by Th1 effectors, while suppressing Th2 polariza-
tion.39 Although much progress has been made in understanding
these late events of Th1 lineage commitment,2 the signaling
pathways triggered early by the TCR and required for Th1 priming
have remained elusive.40 Now, we show that CD4 T cells lacking
H-ras or N-ras are both intrinsically defective in inducing IFN-
and T-bet early after TCR engagement and exhibit impaired
differentiation into Th1 effectors during early L major infection,
strongly supporting that the TCR signals necessarily through H-ras
and N-ras to mediate early Th1 priming and polarization, which is
relevant for establishment of protective Th1 responses in vivo.
In a transgenic mouse expressing a dominant-negative form of
Ras in T cells, thymocyte positive selection11 and Th2 polariza-
tion12 were impaired strongly. However, because of its mechanism
of action, that it, sequestration of activating GEFs,13 this dominant-
negative approach cannot discriminate between contributions from
different Ras isoforms.14 Of note, dominant-negative Ras markedly
suppressed TCR-mediated ERK activation, but not other signaling
events, in immature and mature T cells,11,12 with this probably
underlying the biologic consequences of its expression. In line with
this, pharmacologic ERK inhibitors mimicked the detrimental
effects of dominant-negative Ras on both positive selection and
Th2 differentiation.12,41 In contrast, T-lineage cells lacking H-ras or
N-ras did not show, in our hands, defective TCR-mediated ERK
activation, which correlated well with their unaffected positive
selection and capability to mount antiparasite Th2 responses in the
context of impaired Th1 immunity.
Although the mechanisms underlying the requirement for H-ras
and N-ras during Th1 differentiation remains to be further deter-
mined, our study clearly places these Ras isoforms upstream from
T-bet and IFN-, seemingly at a stage before the action of IL-1226,42
and unveils a critical function for them in the establishment of
protective Th1 immunity to L major. Because Ras-deficient mice
ultimately develop strong Th2 responses to L major, it could be
argued that H-ras and N-ras are also required for suppression of
Th2 responsiveness, as observed for instance in JNK1-deficient
mice.43 This is unlikely to be the case, because in vitro TCR-
activated H-ras– and N-ras–deficient T cells, in contrast to their
JNK1-lacking counterparts, did not show an early bias toward a
Figure 6. Unimpaired DC and macrophage function but
defective Th1 differentiation in vivo in mice lacking H-ras
or N-ras. (A) IL-12 production by LPS- or CpG-ODN–
stimulated (48 hours) BM-derived DCs from WT, H-ras–, and
N-ras–deficient mice (mean  SD of duplicate cultures and
2 mice per group), as determined by ELISA (*P  .005 and
**P  .001 vs WT). (B) BM-derived macrophages from mice
of the indicated genotype were stimulated for 24 hours with-
out or with IFN- (100 U/mL) or IFN- plus LPS (2 g/mL),
followed by assessment of NO production measured as nitrite
(mean  SD of duplicate cultures and 2 mice per group).
(C) Draining LN cells (5  105) from L major–infected (week 3
after infection) mice of the indicated genotype were cultured
with 1  105 WT DCs presenting SLA (12 g/mL). Cytokine
production was determined after 24 hours by intracellular
cytokine staining in gated CD4T cells (right) or after 48 hours
by ELISA (left; mean  SD of duplicate cultures and 2 mice
per group; *P  .03 vs WT). Numbers within dot plots indicate
percent cells in the gated regions. (D) IL-17 response to SLA
of draining LN cells from infected (weeks 1 and 3 after
infection) mice, as measured by fluorescent bead assay
(mean  SD of 2 mice per group; *P  .05 vs WT).
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Th2 cytokine response, even when Th2-polarizing conditions are
provided. Moreover, Th2 cells were gradually augmented in Ras
mutants after parasite challenge, with overt Th2 responses being
detected only at late phases of infection and probably as result of
the failure of Ras-deficient mice to mount an effective Th1
response opposing the expansion of Th2 cells. Further supporting
this notion, administration of CpG-ODNs at the time and site of
parasite challenge completely protected Ras-deficient mice against
an otherwise progressive infection. This protective effect is prob-
ably related to the well-established Th1-promoting properties of
CpG-ODNs, including improvement of antigen presentation and
production of Th1-biasing cytokines (ie, IL-12) by APCs.27 Consis-
tent with this, Ras-deficient DCs were capable of inducing MHC,
costimulatory molecules, and IL-12 expression in response to
CpG-ODNs in vitro, suggesting that they, and probably other
immune cells, could be also stimulated in vivo by CpG-ODNs to
rescue the Th1-priming defect and to allow Th1 responses to ensue
in Ras-deficient mice.33 Thus, lack of H-ras– or N-ras–mediated
signaling during thymocyte development does not seemingly
imprint an absolute and irreversible inability for T cells to become
Th1 or Th2 effectors in the periphery. Instead, H-ras and N-ras
appear to be critical for optimal TCR-mediated induction of IFN-
in mature CD4 T cells, but whether this trait is imprinted in the
thymus remains unclear. Further progress on these issues awaits the
generation and analysis of mice with disrupted Ras function
specifically in mature T cells. Curiously enough, in vitro TCR-
stimulated CD4 T cells from the T cell–specific Ras–dominant-
negative transgenic mice, in contrast to H-ras– and N-ras–deficient
T cells shown here, displayed increased production of IFN- and
normal Th1 polarization.12 The latter raises the question as to
whether the dominant-negative Ras protein in T cells actually
targets H-ras, N-ras, both, or neither isoform or other member(s) of
the Ras superfamily.13
H-ras and N-ras are highly related in structure, share mecha-
nism of action,7 and can be both activated in response to TCR
engagement. Thus, it is intriguing that they cannot compensate
each other for Th1 polarization leading to protective Th1 immunity.
One possible explanation could be that active forms of H-ras and
N-ras trigger distinct downstream pathways critical for Th1
development. Alternatively, they could engage the same Th1-
promoting pathway(s) but acting in a cooperative manner.44 Further
complexity in the interplay between Ras isoforms will also
probably emerge from their distinct sensitivity to the TCR signal
strength45 or unique function or both in particular intracellular
compartments.8 Further studies are thus required to elucidate these
issues.
The selective coupling of individual Ras isoforms to the TCR in
mature but not immature T cells, and particularly for peripheral Th
differentiation, is reminiscent of that reported for some members of
other isoenzyme families, such as PKC-21 and the GTPase Rac2,46
which suggests a conserved mechanism allowing differential
signaling from the TCR, depending of the differentiation state of
the cell. Rac2-deficient T cells developed normally in the thymus
but showed decreased IFN- production under Th1 conditions in
vitro.47 Interestingly enough, Rac2-deficient mice did not display
increased susceptibility to L major,48 suggesting that the role of
Rac2 in Th1 responses to infection in vivo, in contrast to that of
H-ras and N-ras described here, is largely redundant.
In conclusion, the identification of specific and overlapping
functions of Ras isoforms,49 as shown here for H-ras and N-ras in
T cells, may have important implications not only for understand-
ing the molecular mechanisms that regulate T-cell differentiation
Figure 7. CpG-ODN protects H-ras– and N-ras–deficient mice from L major
infection. (A) Course of L major infection in CpG-ODN–treated WT, H-ras–, and
N-ras–deficient mice. Mean induration  SD of 2-3 mice (4-6 ears) per group are
shown. Dotted line represents the evolution of infection in untreated WT mice.
(B) Parasite burden per ear in infected CpG-ODN–treated mice at weeks 3 and 8 after
infection. Results represent mean  SD for 2 mice per group. (C) IFN- and IL-4
production, as determined by ELISA, by draining LN cells isolated from untreated ()
or CpG-ODN–treated () L major–infected mice at week 3 after infection and
stimulated with SLA (12 g/mL) for 48 hours. Values represent the mean  SD of
duplicate cultures and 4 mice in each group of untreated mice (*P  .01 and
**P  .001 vs untreated WT) or 2 mice in the CpG-ODN–treated groups. IL-4 was not
detectable in CpG-ODN–treated mice regardless of their genotype.
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and responses but also for development of more specific Ras
modulators50 that could be promising therapeutics, individually or
in combination with other immunomodulators, for the regulation of
Th cells in infection, inflammation, and autoimmunity.
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